Insider trades
Grant Pickering, CEO of Vaxcyte PCVX, has filed 2 purchases and 135 sales on the open market. Over the past 12 months that comes to a net sale of $2.6M. The latest trade was on 06/26.
Grant Pickering
CEO
- Company
- Vaxcyte PCVX
- First filing
- 23/01/04
- Trades
- 214 trades
- Buys / sales
- 2 / 135
- 12-month net buying
- −$2.6M
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/26 | 06/26 | 24,237 sh9 trades | $55.22avg. | $1,338,346.74 | No record | |
| Open-market sale10b5-1 plan | 06/18 | 06/18 | 24,461 sh4 trades | $52.50avg. | $1,284,204.75 | No record | |
| Open-market sale10b5-1 plan | 24/12/09 | 24/12/10 | 2,366 sh4 trades | $92.24avg. | $218,251.13 | −1.7% | |
| Open-market sale10b5-1 plan | 24/12/02 | 24/12/03 | 15,000 sh3 trades | $92.45avg. | $1,386,793 | −3.2% | |
| Open-market sale10b5-1 plan | 24/11/07 | 24/11/08 | 2,366 sh8 trades | $103.89avg. | $245,797.62 | −1.7% | |
| Open-market sale10b5-1 plan | 24/11/01 | 24/11/04 | 15,000 sh3 trades | $106.82avg. | $1,602,254.83 | −3.3% | |
| Open-market sale10b5-1 plan | 24/10/07 | 24/10/08 | 7,098 sh8 trades | $109.21avg. | $775,149.25 | −4.9% | |
| Open-market sale10b5-1 plan | 24/10/01 | 24/10/03 | 55,000 sh9 trades | $114.25avg. | $6,283,800.64 | −10.9% | |
| Open-market sale10b5-1 plan | 24/08/23 | 24/08/26 | 15,000 sh2 trades | $78.98avg. | $1,184,738.4 | −3.0% | |
| Open-market sale10b5-1 plan | 24/08/01 | 24/08/05 | 2,616 sh2 trades | $78.79avg. | $206,114.64 | −1.8% | |
| Open-market sale10b5-1 plan | 24/07/23 | 24/07/24 | 15,000 sh2 trades | $84.26avg. | $1,263,947.4 | −3.0% | |
| Open-market sale10b5-1 plan | 24/07/01 | 24/07/02 | 2,616 sh4 trades | $76.33avg. | $199,689.05 | −1.8% | |
| Open-market sale10b5-1 plan | 24/06/24 | 24/06/25 | 15,000 sh3 trades | $75.64avg. | $1,134,602.46 | −3.0% | |
| Open-market sale10b5-1 plan | 24/06/03 | 24/06/05 | 2,616 sh6 trades | $72.06avg. | $188,517.46 | −1.8% | |
| Open-market sale10b5-1 plan | 24/05/23 | 24/05/28 | 15,000 sh2 trades | $69.43avg. | $1,041,389 | −3.0% | |
| Open-market sale10b5-1 plan | 24/05/01 | 24/05/03 | 2,616 sh6 trades | $61.71avg. | $161,421.5 | −1.8% | |
VaxcytePCVX | Open-market sale10b5-1 plan | 24/04/23 | 24/04/25 | 15,000 sh | $61.92 | $928,800 | −3.0% |
| Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 2,616 sh5 trades | $66.71avg. | $174,500.56 | −1.7% | |
| Open-market sale10b5-1 plan | 24/03/25 | 24/03/27 | 15,000 sh2 trades | $66.94avg. | $1,004,026.5 | −3.0% | |
| Open-market sale10b5-1 plan | 24/03/01 | 24/03/04 | 2,616 sh6 trades | $73.70avg. | $192,801.26 | −1.7% |